Iris Dorbian

OrbiMed Asia leads Series A round for CBT Pharmaceuticals

Santa Clara, California-based CBT Pharmaceuticals, a developer of cancer treatments, has raised $9.75 million in Series A financing. OrbiMed Asia led the round.

Rheo scores $2.3 mln seed

Personalized video channel Rheo has raised $2.3 million in seed funding. Accomplice led the round with participation from other backers that included Pathbreaker Ventures, Social Capital and Social Starts.

Denali racks up $130 mln Series B

South San Francisco-based Denali Therapeutics Inc, which is focused on developing treatments for patients with neurodegenerative diseases, has raised $130 million in Series B financing. Baillie Gifford led the round with participation from other investors that included ARCH Venture Partners, F-Prime Biosciences, Flagship Ventures and the Alaska Permanent Fund.

InterWest Partners backs Gobiquity

Scottsdale, Arizona-based Gobiquity, a provider of mobile vision screening technology, has secured $6 million in Series B funding. The investor was InterWest Partners.

Songkick takes in $15 mln

Songkick, an artist-ticketing and concert discovery platform, has raised $15 million in funding. The investor was Access Industries. In addition to the funding, Songkick has hired Lydia Goldberg as vice president of product and Lee Martin as vice president of design.

Grabr picks up $3.5 mln

San Francisco-based Grabr, an international goods platform, has raised $3.5 million in funding. Alexey Repik of RBV Capital led the round.

Inscopix bags $10 mln Series A

Inscopix Inc, a brain mapping platform developer, has raised $10 million in Series A financing. The investors were Playground Ventures, AME Cloud Ventures and Floodgate Fund.

Symphony Commerce pulls in $11 mln

Symphony Commerce, a provider of web store, inventory management and fulfillment capabilities, has raised $11 million in funding. The investors were CRV, Blue Cloud Ventures, Bain Capital Ventures and FirstMark Capital.

Danhua Capital closes second fund at $250 mln

Danhua Capital has raised $250 million for its second venture fund, according to an SEC filing. As previously reported, its initial target was $200 million.

Sample6 fetches $12.7 mln Series C

Cambridge, Massachusetts-based Sample6, a synthetic biology diagnostic company, has raised $12.7 million in Series C funding. Acre Venture Partners led the round with participation from Valley Oak Investments, Canaan Partners and Cultivian Sandbox Ventures.